Results 291 to 300 of about 1,855,857 (359)

Effects of curcumin on metabolic and systemic diseases: Narrative review

open access: diamond
Wendy Fiorella Cruz-Bacilio   +4 more
openalex   +2 more sources

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Preclinical research in obesity-associated metabolic diseases using in vitro, multicellular, and non-mammalian models. [PDF]

open access: yesJ Physiol Biochem
Aranaz P   +18 more
europepmc   +1 more source

Global, regional and national burden of asthma attributable to metabolic diseases from 1990 to 2021 and projected trends to 2040. [PDF]

open access: yesBMC Pulm Med
Zhang ZQ   +10 more
europepmc   +1 more source

Analysis Using Various Models on the Effect of Metabolic Surgery on Cardiovascular Disease Risk in the Chinese Population with Obesity

open access: gold
Zheng Wang   +14 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy